Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
25-2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #110298
advertisement
Jørstad ØK
18
Showing records 1 to 18 |
Display all abstracts from
Jørstad ØK
124976
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study
Simonsen E
Diabetes, obesity & metabolism
2025; 27: 3094-3103
124962
Validation of the European visual field standards for driving: A driving simulator-based study
Sudmann TM
Acta Ophthalmologica
2025; 103: 222-231
124976
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study
Lund LC
Diabetes, obesity & metabolism
2025; 27: 3094-3103
124962
Validation of the European visual field standards for driving: A driving simulator-based study
Torblaa A
Acta Ophthalmologica
2025; 103: 222-231
124976
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study
Ernst MT
Diabetes, obesity & metabolism
2025; 27: 3094-3103
124962
Validation of the European visual field standards for driving: A driving simulator-based study
Austeng D
Acta Ophthalmologica
2025; 103: 222-231
124976
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study
Hjellvik V
Diabetes, obesity & metabolism
2025; 27: 3094-3103
124962
Validation of the European visual field standards for driving: A driving simulator-based study
Reshodko I
Acta Ophthalmologica
2025; 103: 222-231
124976
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study
Hegedüs L
Diabetes, obesity & metabolism
2025; 27: 3094-3103
124962
Validation of the European visual field standards for driving: A driving simulator-based study
Rehm J
Acta Ophthalmologica
2025; 103: 222-231
124976
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study
Hamann S
Diabetes, obesity & metabolism
2025; 27: 3094-3103
124962
Validation of the European visual field standards for driving: A driving simulator-based study
Bro T
Acta Ophthalmologica
2025; 103: 222-231
124976
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study
Jørstad ØK
Diabetes, obesity & metabolism
2025; 27: 3094-3103
124962
Validation of the European visual field standards for driving: A driving simulator-based study
Brækhus A; Klungsøyr O
Acta Ophthalmologica
2025; 103: 222-231
124976
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study
Gulseth HL; Karlstad Ø
Diabetes, obesity & metabolism
2025; 27: 3094-3103
124962
Validation of the European visual field standards for driving: A driving simulator-based study
Rowe F
Acta Ophthalmologica
2025; 103: 222-231
124976
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish-Norwegian cohort study
Pottegård A
Diabetes, obesity & metabolism
2025; 27: 3094-3103
124962
Validation of the European visual field standards for driving: A driving simulator-based study
Jørstad ØK
Acta Ophthalmologica
2025; 103: 222-231
Issue
25-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept